The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / New Paradigm Investing


Subject:  Re: IONS Date:  4/20/2018  2:19 PM
Author:  Treepak Number:  93209 of 118187

The deal w BIIB is up to $270 million in milestones per drug plus royalty up to 20% revenue. And, I don’t know of a milestone payment these guys have missed.
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us